Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies’ consensus document | Heart (bmj.com)

Despite advancements in cardiovascular care, heart valve disease remains an important health issue, particularly for women in the UK and around the world. A new consensus document released by the British Cardiovascular Society (BCS) , co-authored by Dr Madalina Garbi, President of the BHVS, sheds light on the significant disparities in the diagnosis and treatment of heart valve disease among women, calling for immediate action to improve care and outcomes.

Research reveals that women with heart valve disease are often underdiagnosed and undertreated, leading to worse health outcomes. The BCS document emphasises that clinical trials frequently exclude female participants, resulting in management strategies that may not adequately address the unique needs of women.

Women face a range of challenges that can exacerbate heart valve disease, including hormonal changes, psychosocial stressors, and socioeconomic disparities. The document advocates for a holistic approach to care that incorporates these sex-specific issues alongside traditional cardiovascular risk factors.

With heart valve diseases largely treatable with timely intervention, this consensus document represents a vital step towards highlighting the specific needs of women.Despite advancements in cardiovascular care, heart valve disease remains an important health issue, particularly for women in the UK and around the world. A new consensus document released by the British Cardiovascular Society (BCS) , co-authored by Dr Madalina Garbi, President of the BHVS, sheds light on the significant disparities in the diagnosis and treatment of heart valve disease among women, calling for immediate action to improve care and outcomes.

Research reveals that women with heart valve disease are often underdiagnosed and undertreated, leading to worse health outcomes. The BCS document emphasises that clinical trials frequently exclude female participants, resulting in management strategies that may not adequately address the unique needs of women.

Women face a range of challenges that can exacerbate heart valve disease, including hormonal changes, psychosocial stressors, and socioeconomic disparities. The document advocates for a holistic approach to care that incorporates these sex-specific issues alongside traditional cardiovascular risk factors.

With heart valve diseases largely treatable with timely intervention, this consensus document represents a vital step towards highlighting the specific needs of women.